Dart NeuroScience, LLC
Patent Applications and Registrations
Patent applications and USPTO patent grants for Dart NeuroScience, LLC.The latest application filed is for "substituted benzoxazole and benzofuran compounds as pde7 inhibitors".
- Dart NeuroScience, LLC - Dallas TX US
- Dart NeuroScience, LLC - San Diego CA US
Trademarks
| Patent | Date |
|---|---|
| Substituted furanopyrimidine compounds as PDE1 inhibitors Grant 11,434,247 - Bookser , et al. September 6, 2 | 2022-09-06 |
| Substituted Benzoxazole And Benzofuran Compounds As Pde7 Inhibitors App 20220267351 - Santora; Vincent John ; et al. | 2022-08-25 |
| Substituted cyclohexyl compounds as NOP inhibiiors Grant 11,365,191 - Thompson , et al. June 21, 2 | 2022-06-21 |
| Substituted pyridine and pyrazine compounds as PDE4 inhibitors Grant 11,279,691 - Bollu , et al. March 22, 2 | 2022-03-22 |
| Substituted Pyrazolopyrimidinone Compounds As Pde2 Inhibitors App 20210340145 - Gomez; Laurent ; et al. | 2021-11-04 |
| Substituted Cyclohexyl Compounds As Nop Inhibitors App 20210340127 - Thompson; Jillian Basinger ; et al. | 2021-11-04 |
| Compounds For Therapeutic Use App 20210198218 - Gomez; Laurent ; et al. | 2021-07-01 |
| Substituted pyrazolopyrimidinone compounds as PDE2 inhibitors Grant 10,981,916 - Gomez , et al. April 20, 2 | 2021-04-20 |
| Compounds for therapeutic use Grant 10,738,018 - Gomez , et al. A | 2020-08-11 |
| Substituted Pyrazolopyrimidinone Compounds As Pde2 Inhibitors App 20200148685 - Gomez; Laurent ; et al. | 2020-05-14 |
| Substituted Methyl Pyrazolopyrimidinone And Methyl Imidazopyrazinone Compounds As Pde1 Inhibitors App 20190177327 - Bookser; Brett ; et al. | 2019-06-13 |
| Compounds For Therapeutic Use App 20180251435 - Gomez; Laurent ; et al. | 2018-09-06 |
| Compounds for therapeutic use Grant 9,963,435 - Gomez , et al. May 8, 2 | 2018-05-08 |
| Compounds For Therapeutic Use App 20180057470 - Gomez; Laurent ; et al. | 2018-03-01 |
| Systems And Methods For Cognitive Testing App 20180055434 - Cheung; Philip ; et al. | 2018-03-01 |
| Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit Grant 9,241,925 - Tully , et al. January 26, 2 | 2016-01-26 |
| Systems, Methods, and Software for Improving Cognitive and Motor Abilities App 20150050626 - Tully; Timothy | 2015-02-19 |
| Substituted Naphthyridine And Quinoline Compounds As Mao Inhibitors App 20140315944 - Basinger; Jillian ; et al. | 2014-10-23 |
| Substituted Pyridine And Pyrazine Compounds As Pde4 Inhibitors App 20140315913 - Bollu; Venkataiah ; et al. | 2014-10-23 |
| Substituted Naphthyridine And Quinoline Compounds As Mao Inhibitors App 20140275548 - Basinger; Jillian ; et al. | 2014-09-18 |
| Substituted Pyridine And Pyrazine Compounds As Pde4 Inhibitors App 20140275531 - Bollu; Venkataiah ; et al. | 2014-09-18 |
| Therapeutic piperazines Grant 8,338,405 - Keenan , et al. December 25, 2 | 2012-12-25 |
| NCAGE Code | 7DEB5 | DART NEUROSCIENCE LLC |
| CAGE Code | 7DEB5 | DART NEUROSCIENCE LLC |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 